Boris D Heifets
Overview
Explore the profile of Boris D Heifets including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santoro M, Lam R, Blumenfeld S, Tan W, Ciari P, Chu E, et al.
NPJ Parkinsons Dis
. 2025 Feb;
11(1):28.
PMID: 39934193
Efforts to develop disease-modifying treatments for Parkinson's disease (PD) have been hindered by the lack of animal models replicating all hallmarks of PD and the insufficient attention to extra-nigrostriatal regions...
2.
Evans A, Park H, Woods C, Lam R, Rijsketic D, Xu C, et al.
J Neuroinflammation
. 2024 Dec;
21(1):322.
PMID: 39696597
Norepinephrine (NE) modulates cognitive function, arousal, attention, and responses to novelty and stress, and it also regulates neuroinflammation. We previously demonstrated behavioral and immunomodulatory effects of beta-adrenergic pharmacology in mouse...
3.
Ryan W, Heifets B
J Psychoactive Drugs
. 2024 Nov;
:1-15.
PMID: 39576028
The use of ketamine and ketamine-assisted psychotherapy (KAP) for treatment of depression has grown dramatically, though much of these data are short term. The clinical profile of maintenance treatment remains...
4.
Evans A, Park H, Woods C, Lam R, Rijsketic D, Xu C, et al.
Res Sq
. 2024 Nov;
PMID: 39574895
Norepinephrine (NE) modulates cognitive function, arousal, attention, and responses to novelty and stress, and also regulates neuroinflammation. We previously demonstrated behavioral and immunomodulatory effects of beta-adrenergic pharmacology in mouse models...
5.
Pomrenze M, Vaillancourt S, Salgado J, Raymond K, Llorach P, Touponse G, et al.
bioRxiv
. 2024 Nov;
PMID: 39484424
MDMA is a promising adjunct to psychotherapy and has well-known abuse liability, although less than other amphetamine analogs. While the reinforcing dopamine (DA)-releasing properties of MDMA are on par with...
6.
Santoro M, Lam R, Blumenfeld S, Tan W, Ciari P, Chu E, et al.
Res Sq
. 2024 Nov;
PMID: 39483924
Efforts to develop disease-modifying treatments for Parkinson's disease (PD) have been hindered by the lack of animal models replicating all hallmarks of PD and the insufficient attention to extra-nigrostriatal regions...
7.
Lii T, Flohr J, Okada R, Cianfichi L, Hack L, Schatzberg A, et al.
medRxiv
. 2024 Oct;
PMID: 39399033
Background: The endogenous opioid system is thought to play a role in the placebo antidepressant response. A recent trial comparing the rapid antidepressant effects of ketamine versus placebo in surgical...
8.
Feng A, Barbosa D, Casey A, Rijsketic D, Salgado J, Huang H, et al.
bioRxiv
. 2024 Sep;
PMID: 39314466
Nucleus accumbens (NAc) deep brain stimulation (DBS) has been increasingly explored as a treatment modality for refractory neuropsychiatric disorders. Uncovering the accumbens network that is engaged by DBS is a...
9.
Denomme N, Heifets B
Am J Psychiatry
. 2024 Sep;
181(9):784-786.
PMID: 39217435
No abstract available.
10.
Hietamies T, Smith A, Lii T, Muzzall E, Flohr J, Okada R, et al.
Br J Anaesth
. 2024 May;
133(1):77-85.
PMID: 38782617
Background: Within the perioperative period, depression-related diagnoses are associated with postoperative complications. We developed a perioperative depression screening programme to assess disease prevalence and feasibility for intervention. Methods: Adult patients...